[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

ZA200805191B - Materials and methods for treating viral infections with a cysteamine compound - Google Patents

Materials and methods for treating viral infections with a cysteamine compound

Info

Publication number
ZA200805191B
ZA200805191B ZA200805191A ZA200805191A ZA200805191B ZA 200805191 B ZA200805191 B ZA 200805191B ZA 200805191 A ZA200805191 A ZA 200805191A ZA 200805191 A ZA200805191 A ZA 200805191A ZA 200805191 B ZA200805191 B ZA 200805191B
Authority
ZA
South Africa
Prior art keywords
materials
methods
viral infections
treating viral
cysteamine compound
Prior art date
Application number
ZA200805191A
Inventor
Liang Hao Yi
Chi Francis
Xu Qingfu
Chan Bill Piu
Original Assignee
Hk Omega Biopharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hk Omega Biopharma Ltd filed Critical Hk Omega Biopharma Ltd
Publication of ZA200805191B publication Critical patent/ZA200805191B/en

Links

Classifications

    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
ZA200805191A 2005-11-28 2006-11-28 Materials and methods for treating viral infections with a cysteamine compound ZA200805191B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US74058405P 2005-11-28 2005-11-28

Publications (1)

Publication Number Publication Date
ZA200805191B true ZA200805191B (en) 2009-08-26

Family

ID=40214736

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200805191A ZA200805191B (en) 2005-11-28 2006-11-28 Materials and methods for treating viral infections with a cysteamine compound

Country Status (2)

Country Link
CN (1) CN101340902B (en)
ZA (1) ZA200805191B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0905451D0 (en) * 2009-03-31 2009-05-13 Novabiotics Ltd Biofilms
GB201021186D0 (en) 2010-12-14 2011-01-26 Novabiotics Ltd Composition
US9328119B2 (en) * 2013-09-12 2016-05-03 Alios Biopharma, Inc. AZA-pyridone compounds and uses thereof
EP3268368A4 (en) 2015-03-11 2018-11-14 Alios Biopharma, Inc. Aza-pyridone compounds and uses thereof
CN106619592A (en) * 2016-11-17 2017-05-10 郑州郑先医药科技有限公司 Medicine for treating acute pharyngitis
EP4125839A4 (en) * 2020-04-01 2024-04-24 Thiogenesis Therapeutics, Inc. Cysteamine precursor compounds for the treatment of betacoronavirus infections

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5554655A (en) * 1991-09-30 1996-09-10 Jess G. Thoene Method of treating HIV infection
DE19817511A1 (en) * 1998-04-20 1999-10-21 Werner Slenczka Treating or preventing skin or mucosal virus infections, e.g. by herpes viruses, using pantothenic acid, dexpanthenol or derivatives
CN1261564C (en) * 2003-12-02 2006-06-28 中国农业科学院哈尔滨兽医研究所 Artificial recombined influenza virus and its application

Also Published As

Publication number Publication date
CN101340902B (en) 2011-01-26
CN101340902A (en) 2009-01-07

Similar Documents

Publication Publication Date Title
AP2877A (en) Materials and methods for treating viral infections with a cysteamine compound
IL184955A0 (en) Tricyclic-nucleoside compounds for treating viral infections
EP2034948A4 (en) Fiber-reinforced composites and method for the manufacture thereof
IL222922A (en) Anti-neuropilin-1 antibodies and uses thereof
PT2343320T (en) Anti-gitr antibodies and uses thereof
PL1961744T3 (en) Basic group-containing compound and use thereof
EP1899994A4 (en) Soft magnetic composite materials
PT1973950E (en) Anti-ephb4 antibodies and methods using the same
EP1899230A4 (en) Handling compressible materials
GB0608938D0 (en) Particulate material
EP1841581A4 (en) Composites and methods for the manufacture and use thereof
ZA200805191B (en) Materials and methods for treating viral infections with a cysteamine compound
EP1921066A4 (en) Pyridylphenol compound and use thereof
GB0607000D0 (en) Handling jitter
EP1862490A4 (en) Carbodiimide compound and uses thereof
GB2429966B (en) Shaft-ring gripper
HK1109939A1 (en) Techniques for handling lock-related inconsistencies
EP1909789A4 (en) Antidiabetic oxazolidinediones and thiazolidinediones
EP1907381A4 (en) Antidiabetic oxazolidinediones and thiazolidinediones
EP1737676A4 (en) Edge cure prevention process
GB0516245D0 (en) Process, composition and compound
EP1904113A4 (en) Neuroprotective effective compound
GB2432359B (en) Closure
GB0520438D0 (en) Material handling
GB0511532D0 (en) Particulate materials